A potentially life-saving treatment containing venom from one of the world’s deadliest spiders is one step closer to human trials, thanks to a $23 million investment in a Brisbane startup.
4 July 2022The University of Queensland-based Protagonist Therapeutics, Inc. has announced the completion of a $14 million Series B venture financing initiative.
10 July 2013A successful Brisbane biotechnology company formed by The University of Queensland’s Institute for Molecular Bioscience (IMB) is expanding its collaboration with a publicly traded pharmaceutical company based on the east coast of the United States.
10 December 2012Wine lovers already appreciate the differences that occur between brands, grape varieties variety and regions and now a world-first project is taking this concept and trying to unlock the signature flavours for some of Australia’s most iconic...
3 August 2011A Queensland biotechnology company has raised US$9 million (about AUS$11.9 million) to fund the development of new types of therapeutic drugs.
22 September 2006A University of Queensland academic has criticised economic rationalism as a "dumb" economic theory and has questioned its rise in Australian political thinking.
5 May 1999The University of Queensland's Centre for Drug Design and Development has launched three spin-off biotechnology companies to further develop intellectual property and commercialise the results of its research.
26 February 1999
